Levonorgestrel And Ethinyl Estradiol Kit
Product Images NDC 60505-4899

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol (NDC 60505-4899). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister-apotex (Blister Apotex)

Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg oral contraceptive kit containing 28 tablets. The label shows a 4-week tablet calendar organized by days Sunday through Saturday. The product is manufactured for Apotex Corp., with storage instructions at controlled room temperature, and includes a barcode.*

FDA Label Image

Carton-apotex (Carton Apotex)

The packaging label for Levonorgestrel and Ethinyl Estradiol Tablets USP, a prescription oral contraceptive kit by Apotex Corp. The label shows dosage strength of 0.15 mg / 0.03 mg per tablet. The kit contains 3 blister cards with a total of 28 tablets. The label includes usage instructions, storage conditions, and manufacturer details.*

FDA Label Image

Figure-2 (Figure 2)

A forest plot chart showing effect estimates (OR/RR) with confidence intervals for various contraceptive studies from 2002 to 2017, including the NICHD Women's Contraceptive Study, French E3N cohort, Shangai Women's Health Study, Nurses' Health Study II, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study. The x-axis represents effect estimates ranging from -1.5 to 2, with most estimates around 1.0 to 1.3.*

FDA Label Image

Levo-ee-ee-structure.jpg (Levo Ee Ee Structure)

Chemical structure of Ethinyl Estradiol, showing its molecular formula C20H24O2 and molecular weight 296.4. The diagram displays the arrangement of atoms including hydroxyl (OH) groups and an ethynyl (C≡CH) group.*

FDA Label Image

Evo-ee-fig1 (Levo Ee Fig1)

A horizontal bar chart comparing the number of women with a blood clot per 10,000 women years among four groups: Non-Pregnant Non-COC users (1 to 5), COC users (3 to 9), Pregnancy (5 to 20), and Postpartum (12 weeks only) (40 to 65). The chart includes a note explaining pregnancy data and duration assumptions.*

FDA Label Image

Levo-ee-fig2 (Levo Ee Fig2)

A vertical chart comparing pregnancy rates per 100 women per year associated with various contraceptive methods. It lists methods from fewer pregnancies (less than 1 per 100 women) such as implants, injections, intrauterine devices, and sterilization; to methods with more pregnancies (10 to 20 per 100 women) like condoms and diaphragms; and methods with even higher pregnancy rates including no sex during fertile days, spermicide, and withdrawal. The highest pregnancy rate category (85 or more per 100 women) corresponds to no birth control.*

FDA Label Image

Levo-ee-levo-structure.jpg (Levo Ee Levo Structure)

Chemical structure of Levonorgestrel showing its molecular formula C21H28O2 and molecular weight 312.4. The diagram depicts the steroid framework with attached chemical groups as part of its molecular composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.